Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How I treat venous thrombosis in children.

Literature DB >> 16099882

How I treat venous thrombosis in children.

Marilyn J Manco-Johnson¹.

Abstract

Entities: Disease Species

Mesh：

Substances：
Anticoagulants

Year: 2005 PMID： 16099882 PMCID： PMC1895344 DOI： 10.1182/blood-2004-11-4211

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

× No keyword cloud information.

67 in total

1. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases.

Authors: N Nohe; A Flemmer; R Rümler; M Praun; K Auberger
Journal: Eur J Pediatr Date: 1999-12 Impact factor: 3.183

2. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.

Authors: U Nowak-Göttl; R Junker; W Kreuz; A von Eckardstein; A Kosch; N Nohe; R Schobess; S Ehrenforth
Journal: Blood Date: 2001-02-15 Impact factor: 22.113

3. Prospective evaluation of endoluminal venous stents in the treatment of the May-Thurner syndrome.

Authors: Jeffrey P Lamont; Gregory J Pearl; Peter Patetsios; Marc T Warner; Dennis R Gable; Wilson Garrett; Bradley Grimsley; Bertram L Smith; William P Shutze
Journal: Ann Vasc Surg Date: 2002-01-17 Impact factor: 1.466

4. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.

Authors: C H van Ommen; H Heijboer; H R Büller; R A Hirasing; H S Heijmans; M Peters
Journal: J Pediatr Date: 2001-11 Impact factor: 4.406

5. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients.

Authors: W Streif; M Andrew; V Marzinotto; P Massicotte; A K Chan; J A Julian; L Mitchell
Journal: Blood Date: 1999-11-01 Impact factor: 22.113

6. Long term complications of inferior vena cava thrombosis.

Authors: M Häusler; D Hübner; T Delhaas; E G Mühler
Journal: Arch Dis Child Date: 2001-09 Impact factor: 3.791

7. The varicella-autoantibody syndrome.

Authors: C Josephson; R Nuss; L Jacobson; M R Hacker; J Murphy; A Weinberg; M J Manco-Johnson
Journal: Pediatr Res Date: 2001-09 Impact factor: 3.756

8. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis.

Authors: Mark H Meissner; Brenda K Zierler; Robert O Bergelin; Wayne L Chandler; D Eugene Strandness
Journal: J Vasc Surg Date: 2002-02 Impact factor: 4.268

9. The use of low molecular weight heparin in pediatric patients: a prospective cohort study.

Authors: D Dix; M Andrew; V Marzinotto; K Charpentier; S Bridge; P Monagle; G deVeber; M Leaker; A K Chan; M P Massicotte
Journal: J Pediatr Date: 2000-04 Impact factor: 4.406

10. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children.

Authors: M J Manco-Johnson; R Nuss; T Hays; W Krupski; J Drose; M L Manco-Johnson
Journal: J Pediatr Date: 2000-04 Impact factor: 4.406

23 in total

Review 1. How We Manage Pediatric Deep Venous Thrombosis.

Authors: Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal: Semin Intervent Radiol Date: 2017-03 Impact factor: 1.513

Review 2. Current and future management of pediatric venous thromboembolism.

Authors: Bryce A Kerlin
Journal: Am J Hematol Date: 2012-02-24 Impact factor: 10.047

3. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.

Authors: Lela S Fung; Christopher Klockau
Journal: J Pediatr Pharmacol Ther Date: 2010-04

4. Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.

Authors: A Moruf; A C Spyropoulos; T Q Schardt; E Gibson; M J Manco-Johnson; M Wang; N A Goldenberg
Journal: Thromb Res Date: 2012-06-29 Impact factor: 3.944